La pérdida ósea marginal en la rehabilitación fija con implantes en pacientes edéntulos. Un estudio a 3 años / Marginal bone loss on fixed rehabilitation with implants in edentulous patients. A 3-year study

Introducción: El objetivo del presente estudio era mostrar los resultados de la pérdida ósea marginal en el tratamiento con rehabilitación fija mediante implantes dentales en pacientes edéntulos totales. Material y Métodos: 24 pacientes edéntulos fueron tratados con 210 implantes KTX ® con superficie arenada y grabada para la rehabilitación total fija. Los implantes fueron cargados inmediatamente en el mismo día de la cirugía. El seguimiento clínico medio fue de 37,1 ±14,6 meses. Resultados: Los hallazgos clínicos indican una supervivencia y éxito de los implantes del 99,5%. Los pacientes fueron rehabilitados con 33 prótesis totales fijas atornilladas. Complicaciones biológicas fueron observadas en el 50% de los pacientes y las complicaciones prostodóncicas en el 4,2% de los pacientes. La pérdida ósea marginal fue de 1,33± 0,77 mm. La pérdida ósea marginal no estuvo relacionada significativamente con la edad, sexo, hábito de fumar, antecedentes médicos, tipos de prótesis y seguimiento clínico. Conclusiones: Este estudio indica que la rehabilitación fija mediante implantes dentales en pacientes edéntulos totales constituye una terapéutica con éxito con una pérdida ósea marginal frecuente. (AU)

Introduction: The aim of this study was to report the outcome of marginal bone loss in the treatment of fully edentulous patients with fixed prostheses supported with dental implants. Material & Methods: 24 edentulous patients were treated with 210 KTX ® sandblasted and acid surface implants for fixed maxilla/mandible rehabilitation. Implants were immediately loaded in the same day of the surgery. The mean follow-up was 37.1 ±14.6 months. Results: Clinical results indicate a survival and success rate of implants of 99.5%. One implant was lost during the follow-up period. The patients were restored with 33 screw fixed rehabilitations. Biological complications were observed in 50% of patients and technical complications in 4.2% of patients. Mean marginal bone loss was 1.33 ± 0. 77 mm. Marginal bone loss are not significantly related with age, gender, smoking, medical background, types of prostheses, and clinical follow-up. Conclusions: This study indicates that fixed rehabilitations by dental implants in totally edentulous patients constitute a successful treatment with a frequent marginal bone loss. (AU)

Atrophic Maxilla Reconstruction With Autogenous Iliac Graft and Guided Dental Implants.

Oral rehabilitation with osseointegrated implants is frequently the best alternative for replacement of lost teeth. Several techniques and materials allow achievement of excellent function and esthetics. In the case of maxillary or mandibular atrophy, extensive grafting may be necessary before implants can be properly placed. This is a case of maxillary reconstruction with autogenous iliac crest bone grafts, followed by placement of guided implants. After integration of the grafts, planning and insertion of implants allowed installation of an implant-supported prosthesis, recovering the morphology, function, and esthetics.

Does early exercise attenuate muscle atrophy or bone loss after spinal cord injury?

OBJECTIVES: To systematically identify and assess the evidence on the efficacy of exercise initiated early after traumatic spinal cord injury (SCI). METHODS: A comprehensive search (Any-2014) of eleven databases identified studies evaluating exercise interventions initiated within 12 weeks after SCI on muscle and bone loss in paralyzed limbs and comparing with standard care or immobilization. Two reviewers assessed methodological quality. One reviewer extracted data and critiqued results according to the Spinal Cord Injury Rehabilitation Evidence body of evidence framework. RESULTS: A total of 2811 titles were screened. Eleven studies were included: five randomized controlled trials, four cohort studies and two within-subject control studies. All provided level II evidence with a moderate risk of bias. Two studies found significant positive effects of high-load FES-resisted stance on physiological measures of muscle. Three reported positive effects of 3 months of Functional Electrical Stimulation (FES) on muscle size. Two studies found positive effects of 6-month body-weight supported treadmill training or FES on trabecular bone using pQCT. CONCLUSION: We found consistent evidence of positive effects of early exercise on muscle, possibly related to load intensity of the protocol. However, the heterogeneity of interventions and outcomes makes this determination speculative. Evidence for the effectiveness of early exercise on bone is scant and confined to measures of trabecular bone mineral density via pQCT. Transparent reporting of methods and variability of data, combined with standardization of valid and sensitive measures of muscle atrophy and bone loss, could facilitate future meta-analysis on this topic.

Associação entre osso autógeno e material heterógeno como forma de otimização de resultado em enxertia óssea: relato de caso / Association between autogenousbone and heterogen graft to optimize outcomes of bone grafting: a case report

Introdução: ainda nos dias atuais, a reabilitação de regiões que apresentam tecido ósseo insuficiente para instalação de implantes dentários permanece um grande desafio ao cirurgião. Nesse sentido, a associação de enxerto autógeno e material heterógeno é reportada na literatura como uma opção viável e previsível, com a capacidade de readequar esses rebordos, tornando-os aptos a receber implantes. Objetivo: o objetivo do presente trabalho é relatar o caso clínico de um paciente que procurou reabilitação com implantes dentários para a região anteros superior, mas cujas avaliações clínica e radiográfica evidenciaram atrofia do rebordo alveolar. Métodos: diante disso, o paciente foi orientado e submetido à reconstrução óssea da região, por meio da remoção de enxerto do mento. Após a remoção do enxerto, esse foi adaptado e fixado à região receptora em associação com material heterógeno e membrana de colágeno reabsorvível. Decorrido cinco meses da cirurgia de enxerto, foi realizada a instalação dos implantes dentários na região, sendo possível observar a excelente incorporação do enxerto e praticamente a ausência de reabsorção do osso autógeno. Conclusão: podemos afirmar que a associação entre osso autógeno e heterógeno mostrou-se uma opção previsível, com pouca ou nenhuma reabsorção, possibilitando a instalação de implantes em posições e proporções adequadas.

Introduction: Even today, rehabilitation of regions with insufficient bone for implant placement remains a major challenge to the surgeon. The combination of autograft and heterogenmaterial is reported in the literature as a viable and predictable option to readjust the edges, rendering them favorable for implant placement. Objective: To report the case of a patient seeking rehabilitation with dental implants for the anterior maxilla, but whose clinical and radiographic examination showed atrophy of the alveolar ridge. Methods: The patient was instructed and subjectedto bone reconstruction with chin graft. After graft harvesting, it was adjusted and set to the receiving region in association with heterogen material and resorbable collagen membrane. Fivemonths after graft surgery, dental implants were installed in the region where excellent graft incorporationand virtually no resorption of autogenous bone were observed. Conclusion: The combination of autogenous bone and heterogen proved to be a predictable option with little or no resorption, allowing implant placement in proper position and proportions.

Actualización en el tratamiento de la osteoporosis. Manejo desde una unidad del dolor (1.ª parte) / Update on the treatment of osteoporosis: management from a unit of pain (I)

La osteoporosis (OP) se define como una enfermedad esquelética caracterizada por una resistencia ósea disminuida que predispone a un aumento en el riesgo de fracturas. En Europa se producen 2,7 millones de fracturas por fragilidad, tanto en hombres como mujeres, con un coste directo de 36 billones de euros. Estas fracturas se asocian con un incremento en la morbilidad y mortalidad. El riesgo de fractura osteoporótica viene determinado por la presencia de uno o más factores de riesgo y el descenso de la densidad mineral ósea (DMO) valorado mediante la técnica Dual Energy X-ray absortiometry (DEXA), densitometría. La indicación de tratamiento se realiza en función del riesgo absoluto de fractura por fragilidad. En los pacientes con un bajo riesgo de fractura son suficientes las medidas higiénicas, prevención de caídas y mantener una ingesta adecuada de calcio y vitamina D. En los pacientes con un riesgo moderado se debe individualizar la necesidad de tratamiento farmacológico e iniciar el tratamiento en aquellos con alto riesgo de fractura. Los fármacos más utilizados son los bifosfonatos, inhibidores de la reabsorción ósea, también se utilizan fármacos osteoanabólicos como la hormona teriparatida y anticuerpos monoclonales como el denosumab (AU)

Osteoporosis (OP) is defined as a skeletal disorder characterized by decreased bone strength, which predisposes to an increase in fracture risk. In Europe produced 2.7 million fragility fractures in both men and women with a direct cost of 36 billion euros. These fractures are associated with increased morbidity and mortality. The risk of osteoporotic fracture is determined by the presence of one or more risk factors and decreased bone mineral density (BMD) assessed by Dual Energy technique absortiometry X-ray (DEXA) densitometry. The indication for treatment is made based on the absolute risk of fragility fracture. In patients with a low risk of fracture are sufficient hygienic measures, preventing falls and maintaining an adequate intake of calcium and vitamin D. In patients with a moderate risk should be individualized drug treatment need and initiate treatment in those at high risk of fracture. The most commonly used drugs are bisphosphonates, inhibitors of bone resorption, also used as hormone teriparatide, osteoanabolic drug and monoclonal antibodies such as denosumab (AU)

Eficácia do tratamento não-cirúrgico em indivíduos com mucosite peri-implantar / Effectiveness of non-surgical treatment in patients with peri-implant mucositis

Tem sido demonstrado que o desenvolvimento da mucosite peri-implantar está associado ao acúmulo de biofilme dentário. Acredita-se que as abordagens terapêuticas utilizadas nas doenças periodontais podem apresentar efeito positivo nos casos de doenças peri-implantares. O objetivo desse estudo foi avaliar a eficácia do tratamento não cirúrgico da mucosite peri-implantar em 119 implantes, sendo 61 no grupo teste (digluconato de clorexidina a 0,12%) e 58 no grupo controle (placebo), em indivíduos reabilitados com implantes. Desta forma, os pacientes foram divididos aleatoriamente em grupo teste (terapia não cirúrgica + clorexidina) e controle (terapia não cirúrgica). Esta terapia consistiu de uma adaptação do protocolo não-cirúrgico FMSRP (Full Mouth Scalling and Root Planing), porém, sem a utilização do ultrassom. Os parâmetros clínicos índice de placa visível (IPV), índice de sangramento gengival (ISG), profundidade de sondagem (PS), sangramento à sondagem (SS) e mucosa queratinizada foram avaliados no baseline e em diferentes períodos após o tratamento. Os dados não apresentaram distribuição normal e o implante foi considerado a unidade amostral. Os dados foram analisados por meio dos testes de Friedman, Wilcoxon e Qui-quadrado (=5%), utilizando o Statistical Package for Social Sciences 17.0 (SPSS). Os resultados mostraram que houve diferença estatisticamente significativa (p<0,05) para as variáveis: média do IPV dos implantes em ambos os grupos; média do ISG dos implantes tanto no grupo teste, como controle dos implantes; PS para o grupo teste e controle e SS dentro dos dois grupos de tratamento. No entanto, não houve diferença estatisticamente significativa quando os grupos foram comparados. As variáveis PS e SS não mostraram diferença estatisticamente significativa com nenhuma variável independente de interesse para este estudo (idade, sexo, fumo, grupo de tratamento, mucosa ceratinizada nos diferentes tempos, biótipo peri-implantar, média do IPV e ISG nos implantes). Desta forma, pode-se concluir que tanto a terapia mecânica isolada como sua associação com bochechos de digluconato de clorexidina a 0,12% podem ser usados para o tratamento da mucosite periimplantar. Além disso, a condição de higiene bucal melhorou entre o baseline e seis meses e a profundidade e sangramento à sondagem reduziram após três e seis meses. (AU)

It has been shown that the development of peri-implant mucositis is associated with biofilm accumulation. It is believed that the therapeutic approaches used in periodontal disease may have a positive effect in the cases of peri-implant disease. The aim of this study was to evaluate the effectiveness of non-surgical treatment of peri-implant mucositis, with or without the use of chlorhexidine 0,12% in subjects rehabilitated with osseointegrated implants. Thus, patients were randomly divided into test group (chlorhexidine surgical therapy) and control (non-surgical treatment). This therapy consisted of an adaptation of the (Full Mouth scalling and Root Planing) nonoperative protocol FMSRP, but without the use of ultrasound. The visible plaque index (VPI), gingival bleeding index (GBI), probing depth (PD), bleeding on probing (BOP) and keratinized mucosa clinical parameters were evaluated at baseline and at different times after treatment. The data were not normally distributed and the implant was considered the sampling unit. Data were analyzed using Friedman and Wilcoxon chi-square (=5%), tests using the Statistical Package for Social Sciences 17.0 (SPSS). Thus, 119 implants were evaluated, 61 in the test group and 58 in the control group. The results showed statistically significant differences for the variables: average BTI implants in both groups (p<0,001), mean ISG implants both in the test group (p<0,001), and control (p= 0,006) of implants; PS for the test group (p< 0,001) and control (p = 0,015) and SS (p<0,001) in the two treatment groups. However, there was no statistically significant difference when the groups were compared. The PS and SS variables showed no statistically significant difference in any of independent interest to the study (age, sex, smoking, treatment group, keratinized mucosa at different times, peri-implant biotype, average VPI implants and GBI). Thus, it can be concluded that both the mechanical treatment isolated as its association with chlorhexidine mouthwash 0.12% can be used for the treatment of peri-implant mucositis. Moreover, the condition of oral hygiene has improved between baseline and six months and the depth and bleeding on probing decreased after three and six months. (AU)

Use of the multi-cup denture for a severely resorbed maxilla: a clinical report.

Obtaining a satisfactory outcome for a patient with a severely resorbed maxilla can be extremely challenging. This clinical report describes the treatment of a patient with a history of multiple implant failures in the maxilla. A conventional upper complete denture had poor retention and so did not fulfil the patient's needs. Further surgery was not considered appropriate. A new upper complete denture was made with a fitting surface covered in multiple suction cups to attempt to improve the retention without surgery and resulted in a pleasing outcome for both the patient and authors.

Bone structure and density via HR-pQCT in 60d bed-rest, 2-years recovery with and without countermeasures.

We examined the effects of bed-rest, recovery and exercise countermeasures on bone density and structure at the distal tibia and radius as measured via high-resolution peripheral computed tomography. 24 subjects underwent 60-days of head-down tilt bed-rest and performed either resistive vibration exercise (RVE; n = 7), resistive exercise only (RE; n = 8) or no exercise (n = 9; 2nd Berlin BedRest Study; BBR2-2). Measurements were performed regularly during and up to 2-years after 60d bed-rest. At the distal tibia marked reductions in cortical area, cortical thickness and bone density but increases in periosteal perimeter and trabecular area were seen (p all<0.001). Recovery of most parameters occurred within 180d after bed-rest. At the distal radius, persistent increases in cortical area, cortical thickness, cortical density and total density and decreases in trabecular area were seen (p all ≤ 0.005). A significant effect of RVE (p = 0.003), but not RE, was seen on cortical area at the distal tibia, with few effects of the countermeasures observed on the remaining parameters. The current study represents the first implementation of high-resolution peripheral computed tomography in bed-rest in male subjects and helps to understand the patterns of bone remodeling due to bed-rest and recovery.

Non-invasive extendible endoprostheses for limb reconstruction in skeletally-mature patients.

We describe the application of a non-invasive extendible endoprosthetic replacement in skeletally-mature patients undergoing revision for failed joint replacement with resultant limb-length inequality after malignant or non-malignant disease. This prosthesis was developed for tumour surgery in skeletally-immature patients but has now been adapted for use in revision procedures to reconstruct the joint or facilitate an arthrodesis, replace bony defects and allow limb length to be restored gradually in the post-operative period. We record the short-term results in nine patients who have had this procedure after multiple previous reconstructive operations. In six, the initial reconstruction had been performed with either allograft or endoprosthetic replacement for neoplastic disease and in three for non-neoplastic disease. The essential components of the prosthesis are a magnetic disc, a gearbox and a drive screw which allows painless lengthening of the prosthesis using the principle of electromagnetic induction. The mean age of the patients was 37 years (18 to 68) with a mean follow-up of 34 months (12 to 62). They had previously undergone a mean of six (2 to 14) open procedures on the affected limb before revision with the non-invasive extendible endoprosthesis. The mean length gained was 56 mm (19 to 107) requiring a mean of nine (3 to 20) lengthening episodes performed in the outpatient department. There was one case of recurrent infection after revision of a previously infected implant and one fracture of the prosthesis after a fall. No amputations were performed. Planned exchange of the prosthesis was required in three patients after attainment of the maximum lengthening capacity of the implant. There was no failure of the lengthening mechanism. The Mean Musculoskeletal Tumour Society rating score was 22 of 30 available points (18 to 28). The use of a non-invasive extendible endoprosthesis in this manner provided patients with good functional results and restoration of leg-length equality, without the need for multiple open lengthening procedures.

A randomized clinical trial comparing patient satisfaction and prosthetic outcomes with mandibular overdentures retained by one or two implants.

PURPOSE: This randomized clinical trial tested hypotheses that there are no differences in patient satisfaction, component costs, or treatment and maintenance times when mandibular overdentures are retained by one or two implants. MATERIALS AND METHODS: Subjects wearing conventional complete dentures were randomized to receive either one midline or two bilateral mandibular implants followed by a mandibular denture reline to incorporate implant retention. They indicated on a visual analog scale satisfaction with their dentures before implants and at 2 months and 1 year after implant retention. Satisfaction outcomes between the two groups were compared using the Wilcoxon/Mann-Whitney nonparametric rank test, while changes within each group were analyzed using signed-rank tests. Component costs and times for surgery, prosthodontic treatment, and maintenance were compared using nonparametric and t tests. RESULTS: Eighty-six subjects enrolled in this study and 85 completed the 1-year follow-up, at which median satisfaction was 93 (maximum 100) in the single-implant group and 94 in the two-implant group (P > .5). Within each group, median improvement in satisfaction was similarly dramatic (approximately 44) and significant (P < .001). Prosthodontic maintenance time was similar for both groups (P > .37), but the single-implant group had significantly lower component costs (P < .001) and lower times for surgery (P = .002), postsurgical denture maintenance (P = .021), and denture reline (P < .001). Five implants failed in four subjects, all in the two-implant group and all before denture reline. CONCLUSION: Lower component costs and treatment times, with comparable satisfaction and maintenance time over the first year, indicate that a mandibular overdenture retained by a single midline implant may be an alternative to the customary two-implant overdenture for maladaptive denture patients.

One-year outcome of narrow diameter blasted implants for rehabilitation of maxillas with knife-edge resorption.

OBJECTIVES: This study aimed at assessing the clinical outcome of narrow diameter implants in the treatment of knife-edge edentulous maxillas of adequate bone height but inadequate width (class IV of Cawood and Howell). MATERIAL AND METHODS: Twelve consecutive patients (eight women and four men, mean age 58 years) with class IV atrophic edentulous maxillas were included in the study. Seventy-three microthreaded TiO(2)-blasted implants were placed and the resonance frequency measured. All the implants had a diameter of 3.5 mm. After 6 months of submerged healing, fixed implant-supported prostheses were delivered to the patients and resonance frequency and radiographic examinations performed. After the first year of loading, the implant outcome was again evaluated clinically, radiographically and with resonance frequency analysis. RESULTS: All the implants were followed up to 1 year of loading and their survival rate was 100%. Bone loss after 1 year of loading was (mean+/-SD) 0.30+/-0.13 mm. Stability values were (mean+/-SD) 63+/-5.8 ISQ at placement, 60+/-4.7 ISQ at the abutment connection and 61+/-5 ISQ after 1 year of loading. A significant difference resulted between placement and abutment connection values (P=0.03). CONCLUSIONS: According to the present study, narrow implants may be used to restore edentulous maxillas with atrophies of class IV of Cawood and Howell. When planning the treatment of edentulous maxillas with such a resorption pattern, this possibility has to be considered as an alternative to more demanding grafting techniques.

Ultrashort sintered porous-surfaced dental implants used to replace posterior teeth.

BACKGROUND: This retrospective multicenter report provides data from a case series of partially edentulous subjects treated with an ultrashort (5-mm-long) sintered porous-surfaced (SPS) dental implant. METHODS: The implant used had a tapered truncated cone shape, was 5-mm long, and had a maximal coronal diameter of 5 mm. Twenty-six implants were placed in 20 subjects to replace primarily maxillary and mandibular molar teeth. Submerged primary healing was used. Nine implants were restored with single crowns, one carried a single cantilever, and the remaining 16 implants were part of fixed implant-supported bridges, generally as the most distal abutment. RESULTS: After functional periods of 1 to 8 years, two maxillary implants failed, giving maxillary and mandibular failure rates of 14.3% and 0%, respectively. CONCLUSION: The results of this case series suggest that an SPS, press-fit, tapered dental implant with a length of 5 mm and a maximal coronal diameter of 5 mm should be investigated further as a solution for the management of highly resorbed posterior sites in partial edentulism, particularly in the mandible.

Rehabilitation of severely resorbed maxillae with zygomatic implants: an update.

Studies highlight the zygomatic bone as a suitable anatomical structure for implant placements since they cross four corticals. Zygomatic implants were described by Branemark in 1988, since then zygomatic implants are indicated in maxillae with atrophy of the posterior area. They have been used in systemic diseases associated with bone loss in this area, and in patients who have suffered radical surgery for maxillofacial tumors. Computed tomography is recommended before placement in order to discount any pathology of the maxillary sinus. The surgical technique has been slightly modified since its description with procedures such as the sinus slot technique. The success rate obtained by different authors varies between 82% and 100%, indicating this technique as a valid treatment option. The objective of this study was to revise the literature with the aim of updating the subject.

Rehabilitación de maxilar con implantes cigomáticos: puesta al día / Rehabilitation of severely resorbed maxillae with zygomatic implants: an update

Los estudios, destacan al hueso cigomático como una buena estructura anatómica donde colocar implantes, ya que se atraviesan cuatro corticales. El procedimiento quirúrgico fue descrito en 1998, por Branemark, desde entonces, los implantes cigomáticos se indican en maxilares con atrofias del sector posterior; se han utilizado en enfermedades sistémicas asociadas a pérdida ósea en esta zona y en pacientes que han sufrido cirugía radical por tumores maxilofaciales. Para su colocación, se recomienda el estudio previo con tomografía computerizada, para descartar patología en el senomaxilar. La técnica quirúrgica desde su descripción ha sido discretamente modificada con procedimientos como el dela ranura sinusal. El porcentaje de éxito obtenido por los distintos autores, se sitúa entre el 82% y 100%, indicando que es una opción de tratamiento válida. El objetivo de este trabajo fue la revisión de la literatura con el fin de actualizar el tema

Studies highlight the zygomatic bone as a suitable anatomical structure for implant placements since they cross fourcorticals. Zygomatic implants were described by Branemark in 1998, since then zygomatic implants are indicated in maxillae withatrophy of the posterior area. They have been used in systemic diseases associated with bone loss in this area, and inpatients who have suffered radical surgery for maxillofacial tumors. Computed tomography is recommended before placement in order to discount any pathology of the maxillary sinus. The surgical technique has been slightly modified since its description with procedures such as the sinus slot technique.The success rate obtained by different authors varies between 82% and 100%, indicating this technique as a valid treat-ment option. The objective of this study was to revise the literature with the aim of updating the subject

Management of a patient with a failed transmandibular implant.

UNLABELLED: The Transmandibular Implant System (TMI) had been developed in order to provide a patient with a severely resorbed mandible with a stable and retensive implant-supported overdenture. Failure of the transmucosal posts may necessitate removal of the transmandibular implant in total and treatment with an implant-supported prosthesis. The purpose of this paper is to describe overcoming failure of a transmandibular implant without removal and synchronous placement of endosseous dental implants in the interforaminal region, providing an implant-retained overdenture to the patient. CLINICAL RELEVANCE: Transmandibular implants are rarely used nowadays and management of a failed transmandibular implant is reported even less often. Where bone height is adequate, dental implants may be placed in the anterior mandible, even when the failed transmandibular implant is not completely removed.

Safety of zygomatic bone harvesting: a prospective study of 32 consecutive patients with simultaneous zygomatic bone grafting and 1-stage implant placement.

PURPOSE: The purpose of this prospective study was to evaluate the safety of zygomatic bone harvesting and to determine whether a particulated zygomatic bone graft can be used simultaneously with 1-stage dental implants to reconstruct resorbed edentulous alveolar ridges. MATERIALS AND METHODS: Altogether, 82 dental implants were placed in 32 patients. Particulated bone grafts harvested from the zygomatic process were used in 72 of the implant sites. The volume of bone harvested, intraoperative complications, morbidity, and complications on follow-up visits were recorded. Implant survival was examined prospectively. RESULTS: As a harvest site, the zygoma yielded enough bone to complete the reconstructions in each case. The average zygomatic bone graft volume was 0.90 mL (SD 0.30). Perforation of the maxillary sinus occurred at 11 zygomatic sites. None of these perforations led to postoperative problems. No paresthesias or other complications were noted during follow-up examinations. Mean duration of postoperative swelling was 4.5 days, and patients used pain medication for a mean duration of 4 days. After the mean follow-up period of 26.9 months postplacement, 80 of 82 implants were osseointegrated (survival rate 97.6%). DISCUSSION: [corrected] Zygomatic bone is an alternative donor site for bone harvesting with low morbidity. The bone graft yielded is sufficient for use in 2 to 3 implant sites. CONCLUSIONS: The zygoma was a safe intraoral bone harvesting donor site in this patient population. Further, the use of simultaneous particulated zygomatic bone grafts and 1-stage implant placement appears to be an effective procedure.